{"entity":{"type":"insider","cik":"0001429931","url":"/insider/0001429931","json_url":"/insider/0001429931.json","name":"KELER TIBOR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2010-09-13","last":"2022-12-09","span_basis":"filed_date"},"name_variants":[{"name":"KELER TIBOR","source":"filing","n_filings":6,"first_seen":"2010-09-13","last_seen":"2022-12-09"}],"transactions":[{"id":6529199,"accession":"0001415889-22-012301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-012301","line_url":"/filing/0001415889-22-012301#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001429931","owner_name":"KELER TIBOR","owner_display_name":"KELER TIBOR","owner_url":"/insider/0001429931","role":"Officer (EXECUTIVE VP & CSO)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VP & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VP & CSO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16860.0,"shares_display":"16,860","price_per_share":36.9283,"price_display":"36.93","price_state":"stated","total_value":622611.138,"total_display":"622,611.14","total_whole":"622,611","shares_owned_after":7357.0,"shares_owned_after_display":"7,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-09","scope":"insider"},{"id":3293261,"accession":"0001179110-20-007164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-007164","line_url":"/filing/0001179110-20-007164#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001429931","owner_name":"KELER TIBOR","owner_display_name":"KELER TIBOR","owner_url":"/insider/0001429931","role":"Officer (Executive VP & CSO)","role_mark":"O","role_mark_label":"Officer (Executive VP & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & CSO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.9908,"price_display":"2.99","price_state":"stated","total_value":14954.0,"total_display":"14,954.00","total_whole":"14,954","shares_owned_after":7357.0,"shares_owned_after_display":"7,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"},{"id":6656020,"accession":"0001179110-18-008669","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-008669","line_url":"/filing/0001179110-18-008669#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001429931","owner_name":"KELER TIBOR","owner_display_name":"KELER TIBOR","owner_url":"/insider/0001429931","role":"Officer (Executive VP & CSO)","role_mark":"O","role_mark_label":"Officer (Executive VP & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & CSO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16500.0,"shares_display":"16,500","price_per_share":0.5929,"price_display":"0.59","price_state":"stated","total_value":9782.85,"total_display":"9,782.85","total_whole":"9,783","shares_owned_after":35368.0,"shares_owned_after_display":"35,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-18","scope":"insider"},{"id":2815759,"accession":"0001179110-16-029306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-029306","line_url":"/filing/0001179110-16-029306#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001429931","owner_name":"KELER TIBOR","owner_display_name":"KELER TIBOR","owner_url":"/insider/0001429931","role":"Officer (Executive VP & CSO)","role_mark":"O","role_mark_label":"Officer (Executive VP & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & CSO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":9960.0,"total_display":"9,960.00","total_whole":"9,960","shares_owned_after":18868.0,"shares_owned_after_display":"18,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-06","scope":"insider"},{"id":8963735,"accession":"0001179110-11-012075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-012075","line_url":"/filing/0001179110-11-012075#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001429931","owner_name":"KELER TIBOR","owner_display_name":"KELER TIBOR","owner_url":"/insider/0001429931","role":"Officer (Sr. VP & CSO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.504,"price_display":"2.50","price_state":"stated","total_value":12520.0,"total_display":"12,520.00","total_whole":"12,520","shares_owned_after":15868.0,"shares_owned_after_display":"15,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-11","scope":"insider"},{"id":7460565,"accession":"0001179110-10-013711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-013711","line_url":"/filing/0001179110-10-013711#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001429931","owner_name":"KELER TIBOR","owner_display_name":"KELER TIBOR","owner_url":"/insider/0001429931","role":"Officer (Sr. VP & CSO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":17600.0,"total_display":"17,600.00","total_whole":"17,600","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-13","filed_date":"2010-09-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000744218","name":"Celldex Therapeutics, Inc.","url":"/issuer/0000744218","role":"Officer (EXECUTIVE VP & CSO)","n_filings":6,"first_seen":"2010-09-13","last_seen":"2022-12-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001429931","retrieved_at":"2026-08-24T16:50:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}